Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Effect of IL-6 Receptor Blockade on Proprotein Convertase Subtilisin/Kexin Type-9 and Cholesterol Efflux Capacity in Rheumatoid Arthritis Patients.

Ferraz-Amaro I, Hernández-Hernández MV, Tejera-Segura B, Delgado-Frías E, Macía-Díaz M, Machado JD, Diaz-González F.

Horm Metab Res. 2019 Mar;51(3):200-209. doi: 10.1055/a-0833-4627. Epub 2019 Jan 29.

PMID:
30695794
2.

Disease Damage Influences Cardiovascular Risk Reclassification Based on Carotid Ultrasound in Patients with Systemic Lupus Erythematosus.

Quevedo-Abeledo JC, Rúa-Figueroa Í, Sánchez-Pérez H, Tejera-Segura B, de Vera-González A, González-Delgado A, Llorca J, González-Gay MÁ, Ferraz-Amaro I.

J Rheumatol. 2019 May;46(5):483-491. doi: 10.3899/jrheum.180881. Epub 2019 Jan 15.

PMID:
30647175
3.

Implication of CXCL5 (epithelial neutrophil-activating peptide 78) in the development of insulin resistance in patients with rheumatoid arthritis.

Tejera-Segura B, López-Mejías R, de Vera-González A, Delgado-González A, González-Gay MA, Ferraz-Amaro I.

Clin Exp Rheumatol. 2019 May-Jun;37(3):373-379. Epub 2018 Sep 17.

4.

Relationship Between Insulin Sensitivity and β-Cell Secretion in Nondiabetic Subjects with Rheumatoid Arthritis.

Tejera-Segura B, López-Mejías R, de Vera-González AM, Jiménez-Sosa A, Olmos JM, Hernández JL, Llorca J, González-Gay MA, Ferraz-Amaro I.

J Rheumatol. 2019 Mar;46(3):229-236. doi: 10.3899/jrheum.180198. Epub 2018 Oct 1.

PMID:
30275261
5.

Identification of a 3'-Untranslated Genetic Variant of RARB Associated With Carotid Intima-Media Thickness in Rheumatoid Arthritis: A Genome-Wide Association Study.

López-Mejías R, Carmona FD, Genre F, Remuzgo-Martínez S, González-Juanatey C, Corrales A, Vicente EF, Pulito-Cueto V, Miranda-Filloy JA, Ramírez Huaranga MA, Blanco R, Robustillo-Villarino M, Rodríguez-Carrio J, Alperi-López M, Alegre-Sancho JJ, Mijares V, Lera-Gómez L, Pérez-Pampín E, González A, Ortega-Castro R, López-Pedrera C, García Vivar ML, Gómez-Arango C, Raya E, Narvaez J, Balsa A, López-Longo FJ, Carreira P, González-Álvaro I, Rodríguez-Rodríguez L, Fernández-Gutiérrez B, Ferraz-Amaro I, Gualillo O, Castañeda S, Martín J, Llorca J, González-Gay MA.

Arthritis Rheumatol. 2019 Mar;71(3):351-360. doi: 10.1002/art.40734. Epub 2019 Jan 18.

6.

Efficacy and Safety of Combined Therapy With Synthetic Disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis: Systematic Literature Review.

Calvo Alén J, Pérez T, Romero Yuste S, Ferraz-Amaro I, Alegre Sancho JJ, Pinto Tasende JA, Maceiras Pan F, Quevedo JC, Hernández-Hernández MV, Hidalgo Calleja C, San Martín Álvarez A, Sánchez MIT, Sanmartí R.

Reumatol Clin. 2018 Sep 18. pii: S1699-258X(18)30175-X. doi: 10.1016/j.reuma.2018.07.016. [Epub ahead of print] English, Spanish.

7.

Amylin in the insulin resistance of patients with rheumatoid arthritis.

Ferraz-Amaro I, López-Mejias R, Tejera-Segura B, de Vera-González AM, Ubilla B, Olmos JM, Hernández JL, González-Gay MA.

Clin Exp Rheumatol. 2018 May-Jun;36(3):421-427. Epub 2018 Jan 15.

PMID:
29352842
8.

Incretins in patients with rheumatoid arthritis.

Tejera-Segura B, López-Mejías R, Domínguez-Luis MJ, de Vera-González AM, González-Delgado A, Ubilla B, Olmos JM, Hernández JL, González-Gay MA, Ferraz-Amaro I.

Arthritis Res Ther. 2017 Oct 17;19(1):229. doi: 10.1186/s13075-017-1431-9.

9.

Undifferentiated connective tissue disease: predictors of evolution into definite disease.

García-González M, Rodríguez-Lozano B, Bustabad S, Ferraz-Amaro I.

Clin Exp Rheumatol. 2017 Sep-Oct;35(5):739-745. Epub 2017 Aug 2.

PMID:
28770704
10.

HDL cholesterol efflux capacity in rheumatoid arthritis patients: contributing factors and relationship with subclinical atherosclerosis.

Tejera-Segura B, Macía-Díaz M, Machado JD, de Vera-González A, García-Dopico JA, Olmos JM, Hernández JL, Díaz-González F, González-Gay MA, Ferraz-Amaro I.

Arthritis Res Ther. 2017 May 31;19(1):113. doi: 10.1186/s13075-017-1311-3.

11.

Validity of the rheumatoid arthritis impact of disease (RAID) score and definition of cut-off points for disease activity states in a population-based European cohort of patients with rheumatoid arthritis.

Salaffi F, Di Carlo M, Vojinovic J, Tincani A, Sulli A, Soldano S, Andreoli L, Dall'Ara F, Ionescu R, Simić Pašalić K, Balčune I, Ferraz-Amaro I, Tlustochowicz M, Butrimienė I, Punceviciene E, Toroptsova N, Grazio S, Morović-Vergles J, Masaryk P, Otsa K, Bernardes M, Boyadzhieva V, Cutolo M.

Joint Bone Spine. 2018 May;85(3):317-322. doi: 10.1016/j.jbspin.2017.05.020. Epub 2017 May 24.

PMID:
28549945
12.

Insulin resistance in systemic lupus erythematosus patients: contributing factors and relationship with subclinical atherosclerosis.

Sánchez-Pérez H, Tejera-Segura B, de Vera-González A, González-Delgado A, Olmos JM, Hernández JL, Corrales A, López-Mejías R, González-Gay MA, Ferraz-Amaro I.

Clin Exp Rheumatol. 2017 Nov-Dec;35(6):885-892. Epub 2017 Mar 8.

PMID:
28281456
13.

European multicentre pilot survey to assess vitamin D status in rheumatoid arthritis patients and early development of a new Patient Reported Outcome questionnaire (D-PRO).

Vojinovic J, Tincani A, Sulli A, Soldano S, Andreoli L, Dall'Ara F, Ionescu R, Pasalic KS, Balcune I, Ferraz-Amaro I, Tlustochowicz M, Butrimiene I, Punceviciene E, Toroptsova N, Grazio S, Morovic-Vergles J, Masaryk P, Otsa K, Bernardes M, Boyadzhieva V, Salaffi F, Cutolo M.

Autoimmun Rev. 2017 May;16(5):548-554. doi: 10.1016/j.autrev.2017.03.002. Epub 2017 Mar 6. Review.

PMID:
28279841
14.

Influence of coronary artery disease and subclinical atherosclerosis related polymorphisms on the risk of atherosclerosis in rheumatoid arthritis.

López-Mejías R, Corrales A, Vicente E, Robustillo-Villarino M, González-Juanatey C, Llorca J, Genre F, Remuzgo-Martínez S, Dierssen-Sotos T, Miranda-Filloy JA, Huaranga MA, Pina T, Blanco R, Alegre-Sancho JJ, Raya E, Mijares V, Ubilla B, Ferraz-Amaro I, Gómez-Vaquero C, Balsa A, López-Longo FJ, Carreira P, González-Álvaro I, Ocejo-Vinyals JG, Rodríguez-Rodríguez L, Fernández-Gutiérrez B, Castañeda S, Martín J, González-Gay MA.

Sci Rep. 2017 Jan 6;7:40303. doi: 10.1038/srep40303.

15.

Cardiovascular risk assessment in patients with rheumatoid arthritis: The relevance of clinical, genetic and serological markers.

López-Mejías R, Castañeda S, González-Juanatey C, Corrales A, Ferraz-Amaro I, Genre F, Remuzgo-Martínez S, Rodriguez-Rodriguez L, Blanco R, Llorca J, Martín J, González-Gay MA.

Autoimmun Rev. 2016 Nov;15(11):1013-1030. doi: 10.1016/j.autrev.2016.07.026. Epub 2016 Aug 1. Review.

16.

Coronary Artery Calcification and Rheumatoid Arthritis: Lack of Relationship to Risk Alleles for Coronary Artery Disease in the General Population.

Ferraz-Amaro I, Winchester R, Gregersen PK, Reynolds RJ, Wasko MC, Oeser A, Chung CP, Stein CM, Giles JT, Bathon JM.

Arthritis Rheumatol. 2017 Mar;69(3):529-541. doi: 10.1002/art.39862.

17.

Proprotein convertase subtilisin/kexin type 9 in rheumatoid arthritis.

Ferraz-Amaro I, López-Mejías R, Ubilla B, Genre F, Tejera-Segura B, de Vera-González AM, González-Rivero AF, Olmos JM, Hernández JL, Llorca J, González-Gay MA.

Clin Exp Rheumatol. 2016 Nov-Dec;34(6):1013-1019. Epub 2016 Aug 31.

PMID:
27606890
18.

Influence of elevated-CRP level-related polymorphisms in non-rheumatic Caucasians on the risk of subclinical atherosclerosis and cardiovascular disease in rheumatoid arthritis.

López-Mejías R, Genre F, Remuzgo-Martínez S, González-Juanatey C, Robustillo-Villarino M, Llorca J, Corrales A, Vicente E, Miranda-Filloy JA, Magro C, Tejera-Segura B, Ramírez Huaranga MA, Pina T, Blanco R, Alegre-Sancho JJ, Raya E, Mijares V, Ubilla B, Mínguez Sánchez MD, Gómez-Vaquero C, Balsa A, Pascual-Salcedo D, López-Longo FJ, Carreira P, González-Álvaro I, Rodríguez-Rodríguez L, Fernández-Gutiérrez B, Ferraz-Amaro I, Castañeda S, Martín J, González-Gay MA.

Sci Rep. 2016 Aug 18;6:31979. doi: 10.1038/srep31979.

19.

Biological therapy and neurological manifestations. What do we know?

Tejera-Segura B, Ferraz-Amaro I.

Reumatol Clin. 2017 Mar - Apr;13(2):102-106. doi: 10.1016/j.reuma.2016.04.012. Epub 2016 Jun 28. Review. English, Spanish.

20.

Serum cathepsin S and cystatin C: relationship to subclinical carotid atherosclerosis in rheumatoid arthritis.

Tejera-Segura B, de Vera-González AM, López-Mejías R, González-Gay MA, Ferraz-Amaro I.

Clin Exp Rheumatol. 2016 Mar-Apr;34(2):230-5. Epub 2016 Feb 26. Erratum in: Clin Exp Rheumatol. 2017 Sep-Oct;35(5):874.

PMID:
26941186
21.

[Reply].

Tejera Segura B, Ferraz-Amaro I.

Med Clin (Barc). 2016 Mar 18;146(6):283. doi: 10.1016/j.medcli.2015.11.003. Epub 2015 Dec 22. Spanish. No abstract available.

PMID:
26726114
22.

Protective Role of the Interleukin 33 rs3939286 Gene Polymorphism in the Development of Subclinical Atherosclerosis in Rheumatoid Arthritis Patients.

López-Mejías R, Genre F, Remuzgo-Martínez S, Robustillo-Villarino M, García-Bermúdez M, Llorca J, Corrales A, González-Juanatey C, Ubilla B, Miranda-Filloy JA, Mijares V, Pina T, Blanco R, Alegre-Sancho JJ, Ramírez Huaranga MA, Mínguez Sánchez MD, Tejera Segura B, Ferraz-Amaro I, Vicente E, Carmona FD, Castañeda S, Martín J, González-Gay MA.

PLoS One. 2015 Nov 16;10(11):e0143153. doi: 10.1371/journal.pone.0143153. eCollection 2015.

23.

Synthetic disease-modifying antirheumatic drug prescribing variability in rheumatoid arthritis: a multilevel analysis of a cross-sectional national study.

Ferraz-Amaro I, Seoane-Mato D, Sánchez-Alonso F, Martín-Martínez MA; emAR II Study Group.

Rheumatol Int. 2015 Nov;35(11):1825-36. doi: 10.1007/s00296-015-3363-5. Epub 2015 Sep 24.

PMID:
26403284
24.

Relationship of abdominal adiposity and body composition with endothelial dysfunction in patients with rheumatoid arthritis.

Delgado-Frías E, González-Gay MA, Muñiz-Montes JR, Gómez Rodríguez-Bethencourt MA, González-Díaz A, Díaz-González F, Ferraz-Amaro I.

Clin Exp Rheumatol. 2015 Jul-Aug;33(4):516-23. Epub 2015 Jul 6.

PMID:
26148347
25.

2014 update of the Consensus Statement of the Spanish Society of Rheumatology on the use of biological therapies in rheumatoid arthritis.

Sanmartí R, García-Rodríguez S, Álvaro-Gracia JM, Andreu JL, Balsa A, Cáliz R, Fernández-Nebro A, Ferraz-Amaro I, Gómez-Reino JJ, González-Álvaro I, Martín-Mola E, Martínez-Taboada VM, Ortiz AM, Tornero J, Marsal S, Moreno-Muelas JV.

Reumatol Clin. 2015 Sep-Oct;11(5):279-94. doi: 10.1016/j.reuma.2015.05.001. Epub 2015 Jun 6. English, Spanish.

26.

TNF-related apoptosis-inducing ligand and cardiovascular disease in rheumatoid arthritis.

Dessein PH, Lopez-Mejias R, Ubilla B, Genre F, Corrales A, Hernandez JL, Ferraz-Amaro I, Tsang L, Pina T, Llorca J, Blanco R, Gonzalez-Juanatey C, Gonzalez-Gay MA.

Clin Exp Rheumatol. 2015 Jul-Aug;33(4):491-7. Epub 2015 May 11.

PMID:
25962765
27.

Relationship between endothelial dysfunction and osteoprotegerin, vitamin D, and bone mineral density in patients with rheumatoid arthritis.

Delgado-Frías E, López-Mejias R, Genre F, Ubilla B, Gómez Rodríguez-Bethencourt MA, González-Díaz A, de Vera-González AM, González-Rivero AF, Díaz-González F, González-Gay MA, Ferraz-Amaro I.

Clin Exp Rheumatol. 2015 Mar-Apr;33(2):241-9. Epub 2015 Mar 10.

PMID:
25797915
28.

[Large vessels vasculopathy in systemic sclerosis].

Tejera Segura B, Ferraz-Amaro I.

Med Clin (Barc). 2015 Dec 7;145(11):488-92. doi: 10.1016/j.medcli.2014.12.016. Epub 2015 Feb 26. Review. Spanish.

PMID:
25726305
29.

Osteoprotegerin concentrations relate independently to established cardiovascular disease in rheumatoid arthritis.

López-Mejias R, Ubilla B, Genre F, Corrales A, Hernández JL, Ferraz-Amaro I, Tsang L, Llorca J, Blanco R, González-Juanatey C, Gonzalez-Gay MA, Dessein PH.

J Rheumatol. 2015 Jan;42(1):39-45. doi: 10.3899/jrheum.140690. Epub 2014 Nov 1.

PMID:
25362655
30.

Recommendations for the management of cardiovascular risk in patients with rheumatoid arthritis: scientific evidence and expert opinion.

Martín-Martínez MA, González-Juanatey C, Castañeda S, Llorca J, Ferraz-Amaro I, Fernández-Gutiérrez B, Díaz-González F, González-Gay MA.

Semin Arthritis Rheum. 2014 Aug;44(1):1-8. doi: 10.1016/j.semarthrit.2014.01.002. Epub 2014 Jan 24. Review.

PMID:
24560170
31.

Retinol-binding protein 4 in rheumatoid arthritis-related insulin resistance and β-cell function.

Ferraz-Amaro I, González-Gay MA, Diaz-González F.

J Rheumatol. 2014 Apr;41(4):658-65. doi: 10.3899/jrheum.130834. Epub 2014 Feb 15.

PMID:
24532832
32.

Influence of disease activity on the physical activity of rheumatoid arthritis patients.

Hernández-Hernández V, Ferraz-Amaro I, Díaz-González F.

Rheumatology (Oxford). 2014 Apr;53(4):722-31. doi: 10.1093/rheumatology/ket422. Epub 2013 Dec 24.

PMID:
24369410
33.

Cholesteryl ester transfer protein in patients with rheumatoid arthritis.

Ferraz-Amaro I, González-Gay MA, García-Dopico JA, Díaz-González F.

J Rheumatol. 2013 Jul;40(7):1040-7. doi: 10.3899/jrheum.121507. Epub 2013 May 15.

PMID:
23678159
34.

Metabolic syndrome in rheumatoid arthritis.

Ferraz-Amaro I, González-Juanatey C, López-Mejias R, Riancho-Zarrabeitia L, González-Gay MA.

Mediators Inflamm. 2013;2013:710928. doi: 10.1155/2013/710928. Epub 2013 Jan 30. Review.

35.

Impaired beta cell function is present in nondiabetic rheumatoid arthritis patients.

Ferraz-Amaro I, García-Dopico JA, Medina-Vega L, González-Gay MA, Díaz-González F.

Arthritis Res Ther. 2013 Jan 22;15(1):R17. doi: 10.1186/ar4149.

36.

Systemic blockade of TNF-α does not improve insulin resistance in humans.

Ferraz-Amaro I, Arce-Franco M, Muñiz J, López-Fernández J, Hernández-Hernández V, Franco A, Quevedo J, Martínez-Martín J, Díaz-González F.

Horm Metab Res. 2011 Oct;43(11):801-8. doi: 10.1055/s-0031-1287783. Epub 2011 Oct 18.

PMID:
22009376
37.

[A woman with joint pain and enlarged upper limbs].

Ferraz-Amaro I, Delgado-Frías E, Hernández-Hernández V, Díaz-González F.

Reumatol Clin. 2011 May-Jun;7(3):210-1. doi: 10.1016/j.reuma.2010.07.003. Epub 2011 Apr 8. Spanish. No abstract available.

38.

[Insulin resistance and rheumatoid arthritis].

Ferraz Amaro I, Díaz González F, González Juanatey C, González Gay MA.

Reumatol Clin. 2011 Mar-Apr;7(2):124-9. doi: 10.1016/j.reuma.2010.03.010. Epub 2011 Jan 14. Review. Spanish.

39.

Pattern of use and safety of non-steroidal anti-inflammatory drugs in rheumatoid arthritis patients. A prospective analysis from clinical practice.

Ferraz-Amaro I, Machín S, Carmona L, González-Alvaro I, Díaz-González F; EMECAR study group.

Reumatol Clin. 2009 Nov-Dec;5(6):252-8. doi: 10.1016/j.reuma.2008.12.015. Epub 2009 May 8.

40.

[The B cell in the pathogenesis of rheumatoid arthritis].

Díaz-González JF, Ferraz Amaro I.

Reumatol Clin. 2007 Jul;3(4):176-82. doi: 10.1016/S1699-258X(07)73617-3. Epub 2008 Nov 13. Spanish.

41.

Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor.

Farooqi IS, Wangensteen T, Collins S, Kimber W, Matarese G, Keogh JM, Lank E, Bottomley B, Lopez-Fernandez J, Ferraz-Amaro I, Dattani MT, Ercan O, Myhre AG, Retterstol L, Stanhope R, Edge JA, McKenzie S, Lessan N, Ghodsi M, De Rosa V, Perna F, Fontana S, Barroso I, Undlien DE, O'Rahilly S.

N Engl J Med. 2007 Jan 18;356(3):237-47.

42.

[The search for new autoantigens in Sjögren's syndrome].

Ferraz-Amaro I, Cozar-Castellano I, Arteaga MF, Machargo MV, Acosta E, Avila J, Bustabad S, Trujillo E, González T, Martín-Vasallo P.

Reumatol Clin. 2005 Dec;1(4):187-92. doi: 10.1016/S1699-258X(05)72743-1. Epub 2008 Dec 20. Spanish.

43.

Dual positivity for cytoplasmic and perinuclear anti-neutrophil antibodies in a patient with Henoch-Schönlein purpura.

Ferraz-Amaro I, Herrero MJ, Jurado A, Díaz-González F.

Clin Exp Rheumatol. 2004 Mar-Apr;22(2):233-4.

PMID:
15083894
44.

[Allergy to corticosteroids, a paradox?].

Ferraz Amaro I, Díaz González F, González T.

Med Clin (Barc). 2003 Feb 8;120(4):141-5. Review. Spanish. No abstract available.

PMID:
12605840

Supplemental Content

Loading ...
Support Center